Remgro’s Mediclinic deal raises concentration risk … but may be worth it
]]>[……] Read More
Hype, poor research and concentration: investors’ biggest risks
You can also listen to this podcast on iono.fm here. This is it – the[……] Read More
You can also listen to this podcast on iono.fm here. This is it – the[……] Read More